Phosphatidylinositol 4,5-Diphosphate

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha ; Homo sapiens







27 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32767959 Docking Studies and Antiproliferative Activities of 6-(3-aryl-2-propenoyl)-2(3H)- benzoxazolone Derivatives as Novel Inhibitors of Phosphatidylinositol 3-Kinase (PI3Kα). 2021 1
2 31816384 Insight into the mechanism of allosteric activation of PI3Kα by oncoprotein K-Ras4B. 2020 Feb 1 2
3 33139939 Phosphatidylinositol-3-OH kinase signalling is spatially organized at endosomal compartments by microtubule-associated protein 4. 2020 Nov 1
4 30747208 Expression and significance of EBV, ARID1A and PIK3CA in gastric carcinoma. 2019 Mar 1
5 30952761 Exon 9 Mutation of PIK3CA Associated With Poor Survival in Patients With Epstein-Barr Virus-associated Gastric Cancer. 2019 Apr 1
6 31135801 The structural basis for Ras activation of PI3Kα lipid kinase. 2019 Jun 5 2
7 31525283 Nicotinic acid affects cytoskeleton remodeling via increasing the activity of gelsolin. 2019 Jul 2
8 31790629 PI3Kα in cardioprotection: Cytoskeleton, late Na+ current, and mechanism of arrhythmias. 2019 Dec 2
9 31802830 Reduced microRNA 375 in colorectal cancer upregulates metadherin-mediated signaling. 2019 Nov 28 1
10 29484141 Association between PIK3CA alteration and prognosis of gastric cancer patients: a meta-analysis. 2018 Jan 26 1
11 29549527 In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS). 2018 May 2
12 29636989 Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece. 2018 1
13 29985963 PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations. 2018 1
14 29211993 Single-Molecule Study Reveals How Receptor and Ras Synergistically Activate PI3Kα and PIP3 Signaling. 2017 Dec 5 1
15 26921096 Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer. 2016 Jun 1
16 28060271 Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures. 2016 Dec 26 1
17 26053643 Molecular spectrum of PIK3CA gene mutations in patients with nonsmall-cell lung cancer in Turkey. 2015 Jul 1
18 26627007 Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations. 2015 Dec 15 1
19 25043846 Engineering of an isolated p110α subunit of PI3Kα permits crystallization and provides a platform for structure-based drug design. 2014 Oct 1
20 25103565 PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors. 2014 Aug 8 1
21 25105564 Structural basis of nSH2 regulation and lipid binding in PI3Kα. 2014 Jul 30 1
22 25309634 Activation of PI3Kα by physiological effectors and by oncogenic mutations: structural and dynamic effects. 2014 Mar 1 4
23 25422220 Detection of PIK3CA gene mutations with HRM analysis and association with IGFBP-5 expression levels in breast cancer. 2014 1
24 19509113 Blocking phosphoinositide 3-kinase activity in colorectal cancer cells reduces proliferation but does not increase apoptosis alone or in combination with cytotoxic drugs. 2009 Jun 1
25 15135396 Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms. 2004 Jun 1
26 10947948 Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases. 2000 Sep 1 1
27 7929193 Biochemical characterization of the free catalytic p110 alpha and the complexed heterodimeric p110 alpha.p85 alpha forms of the mammalian phosphatidylinositol 3-kinase. 1994 Oct 7 1